Antibiotic-induced release of endotoxin: In-vitro comparison of meropenem and other antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 163-169

  Trautmann, M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMIPENEM; MEROPENEM; MONOCLONAL ANTIBODY; TOBRAMYCIN;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; NONHUMAN; SPHEROPLAST;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; CEFTAZIDIME; CIPROFLOXACIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMIPENEM; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; O ANTIGENS; THIENAMYCINS; TOBRAMYCIN;

EID: 0031895327     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.2.163     Document Type: Article

References (31)

1. Cross, A. S. & Opal, S. M. (1995). Endotoxin's role in Gramnegative bacterial infection. Current Opinion in Infectious Diseases 8,156-63.
2. Shenep, J. L & Morgan, K. A. (1984). Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. Journal of Infectious Diseases 150,380-8.
3. Van den Berg, C., de Neeling, A. J., Schot, C. S., Hustinx, W. N. M., Wemer, J. & de Wildt, D. J. (1992). Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scandinavian Journal of Infectious Diseases 24, 619-27.
4. Goto, H. & Nakamura, S. (1980). Liberation of endotoxin from Escherichia coli by addition of antibiotics. Japanese Journal of Experimental Medicine 50,35-43.
5. Shenep, J. L, Barton, R. P. & Morgan, K. A. (1985). Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. Journal of Infectious Diseases 151,1012-8.
6. Jackson, J. J. & Kropp, H. (1992). β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases 165,1033-41.
7. Bucklin, S. E., Fujihara, Y., Leeson, M. C. & Morrison, D. C. (1994). Differential antibiotic-induced release of endotoxin from Gram-negative bacteria. European Journal of Clinical Microbiology and Infectious Diseases 13, Suppl. 1,43-51.
8. Dofferhoff, A. S. M., Nijland, J. H., de Vries-Hospers, H. G., Mulder, P. O. M., Weits, J. & Bom, V. J. J. (1991). Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro and in vivo study. Scandinavian Journal of Infectious Diseases 23,745-54.
9. Prins, J. M. (1995). Antimicrobial Therapy of Severe Gramnegative Infections. Dosing of Aminoglycosides and Studies on Endotoxin Release. Academisch Proefschrift, University of Amsterdam.
10. Mock, C. N., Jurkovich, G. J., Dries, D. J. & Maier, R. V. (1995). Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Archives of Surgery 130,1234-41.
11. Prins, J. M., van Deventer, S. J. H., Kuijper, E. J. & Speelman, P. (1994). Clinical relevance of antibiotic-induced endotoxin release. Antimicrobial Agents and Chemotherapy 38,1211-8.
12. Catchpole, R. C., Wise, R., Thornber, D. & Andrews, J. M. (1992). In vitro activity of L-627, a new carbapenem. Antimicrobial Agents and Chemotherapy 36,1928-34.
13. Hoban, D. J., Jones, R. N., Yamane, N., Frei, R., Trilla, A. & Pignatari, A. C. (1993). In vitro activity of ttiree carbapenem antibiotics. Comparative studies with biapenem (£-627), imipenem, and meropenem against aerobic pathogens isolated worldwide. Diagnostic Microbiology and Infectious Disease 17,299-305.
14. Sumita, Y., Fukasawa, M. & Okuda, T. (1990). Comparison of two carbapenems, SM-7338 and imipenern: affinities for penicillinbinding proteins and morphological changes. Journal of Antibiotics 43,314-20.
15. Pryka, R. D. & Half, G. M. (1994). Meropenem: a new carbapenem antimicrobial. Annals ofPharmacotherapy28,1045-54.
16. Cross, A. S., Gemski, P., Sadoff, J. C., Ørskov, F. & Ørskov, I. (1984). The importance of the K1 capsule in invasive infections caused by Escherichia coli. Journal of Infectious Diseases 149, 184-93.
17. Trautmann, M., Cross, A. S., Reich, G., Held, H., Podschun, R. & Marre, R. (1996). Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. Journal of Medical Microbiology 44,44-51.
18. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically-Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
19. Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. Journal of Bacteriology 154, 269-77.
20. Kaufman, B. M., Cross, A. S., Futrovsky, S. L, Sidberry, H. F. & Sadoff, J. C. (1986). Monoclonal antibodies reactive with K1encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge. Infection and Immunity 52, 617-9.
21. McConnell, J. S. & Cohen, J. (1986). Release of endotoxin from Escherichia coli by quinolones. Journal of Antimicrobial Chemotherapy 18,765-6.
22. Eng, R. H. K., Smith, S. M., Fan-Havard, P. & Ogbara, T. (1993). Effect of antibiotics on endotoxin release from Gramnegative bacteria. Diagnostic Microbiology and Infectious Diseases 16,185-9.
23. Bhattacharjee, A. K., Opal, S. M., Taylor, R., Naso, R., Semenuk, M., Zollinger, W. D. etal. (1996). A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Re chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against Gramnegative bacteremia. Journal of Infectious Diseases 173,1157-63.
24. Artenstein, A. W. & Cross, A. S. (1989). Inhibition of endotoxin reactivity by aminoglycosides. Journal of Antimicrobial Chemotherapy 24, 826-8.
25. Ramirez, C. A., Bran, J. L, Mejia, C. R. & Garcia, J. F. (1985).
26. Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrobial Agents and Chemotherapy 28,128-32.
27. Edelman, R. & Levine, M. M. (1986). Summary of an international workshop on typhoid fever. Reviews of Infectious Diseases 8, 329-49.
28. Dutta, P., Rasaily, R., Saha, M. R., Mitra, U., Bhattacharya, S. K., Bhattacharya, M. K. & Lahiri, M. (1993). Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrobial Agents and Chemotherapy 37,1197-9.
29. Mattsby-Baltzer, I., Lindgren, K., Lindholm, B. & Edebo, L. (1991). Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infection and Immunity 59, 689-95.
30. Bucklin, S. E. & Morrison, D. C. (1995). Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis. Journal of Infectious Diseases 172, 1519-27.
31. Jackson, J. J. & Kropp, H. (1995). Carbapenem- and cephalosporin-induced release of lipopolysaccharide from smooth and rough Pseudomonas aeruginosa: in vivo relevance. In Differential Release and Impact of Antibiotic-induced Endotoxin (Faist, E., Ed.), pp. 21-35. Merck, Whitehouse, NJ.